120 participants
A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-22
- Start Date:
- 2025-02-18
- Completion:
- 2026-11-23
Conditions
- Neoplasms, Colon
Interventions
- BIOLOGICAL
- DRUG
No Results Yet